Twist Bioscience, a US-based DNA manufacturing technology developer backed by genomics technology company llumina, pharmaceutical firm WuXi PharmaTech and biotechnology producer Institut Mérieux, received $33m from undisclosed investors on Monday.
Twist is developing a semiconductor-based process that uses silicon to produce synthetic DNA for eventual use in areas such as personalised medicines and pharmaceuticals, sustainable chemicals and agriculture. It is also working on large-scale data storage technology.
The company has not disclosed the identity of the round’s participants but 28…
